CEBPB and breast carcinoma: In support of this, reduced staining of C/EBPβ is seen in various samples of ductal breast carcinomas presented in the Human Protein Atlas database.34 Future studies using a more large-scale approach will determine whether immunohistochemical staining of C/EBPβ could be used as prognostic tool in breast cancer.